Skip to main content
OpenTrials
Completed

NCT Number: NCT04232956

Invasive Pulmonary Aspergillosis and Severe Influenza

Invasive pulmonary aspergillosis (IPA) has been reported in critically ill patients with influenza infection with a highly variable incidence between 1 to 21%. Studies investigating IPA in critically ill patients with influenza infection suffer limitations in their methods. It remains unknown whether patients with influenza are more at risk of IPA than other patients hospitalized in intensive care unit and whether patients with influenza who develop IPA have specific risk factors for this infection.

Our study aims to determine the incidence of IPA in a large multicenter cohort and to identify risk factors for IPA in these patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Aspergillosis Bacterial Infections and Mycoses Critical Illness Disease Attributes Infections Influenza Influenza, Human Mycoses Orthomyxoviridae Infections Pathologic Processes Pathological Conditions, Signs and Symptoms RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest, Brest, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infection with influenza A or B
  • Admission to one of the participating sites

Exclusion criteria

  • age < 18
  • patients with invasive pulmonary aspergillosis prior to intensive care admission
  • consent withdraw

Treatment and study plan

Primary outcomes

  1. Invasive Pulmonary Aspergillosis

    Time frame: up to 100 days

    incidence of invasive pulmonary aspergillosis

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Is Invasive Pulmonary Aspergillosis a Common Complication of Severe Influenza ?

Acronym: ASPERGIGRIPP

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jan 18, 2020
Registry last updated
Jan 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.